When To Pause, Adjust, Or Seek Medical Review While most side effects are manageable, there are times when you should seek a medical review
NADPH: nicotinamide adenine dinucleotide phosphate

Several factors influence whether Ozempic might be appropriate for someone with Crohn's disease: Disease activity : Patients in stable remission may tolerate the medication differently than those with active inflammation Location of disease : Gastric or upper gastrointestinal involvement might be more problematic given Ozempic's effect on gastric emptying Nutritional status : Individuals already struggling with malabsorption or weight loss may be at higher risk Concurrent medications : While no clinically relevant interactions with common oral medications have been established for subcutaneous semaglutide, monitoring may be prudent Additional important cautions with semaglutide include: Risk of worsening diabetic retinopathy, particularly with rapid glycaemic improvement Increased risk of gallbladder disease, especially with substantial weight loss Potential for dehydration leading to renal impairment Increased risk of hypoglycaemia when used with sulfonylureas or insulin The MHRA and EMA have not issued specific warnings regarding Ozempic use in IBD patients beyond the general caution for severe gastrointestinal disease

It's available on Amazon or from Lifelink Last edited: #5 I also noticed in Roops signature that you are giving 5 units of insulin
[DOI] [PubMed] [Google Scholar] 92.Nagar S, Walther S, Blanchard RL
Lawyers advising research sites, medspas, online sellers, compounding pharmacies and telemedicine organizations should ensure their clients understand the new risks